1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. AMGEN INC.
AMGEN Inc.
XNAS: AMGN

Amgen Live Stock Price Today, Share Analysis and Chart

Mid-range Performer
about

Amgen is a leader in biotechnology-based human therapeutics. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first ...

Read More
331.11 1.52 (0.46%)
26.65% Gain from 52W Low
2.9M
XNAS Volume

XNAS 06 May, 2026 5:30 PM (EDT)

Watchlist

Portfolio

Alert
Dividend
Amgen has an upcoming dividend of $2.52 per share due on 15 May 2026 See details
Durability score
Medium Financial Strength
44.4 / 100
Valuation Score
Mid Valuation
41.5 / 100
Momentum Score
Technically Neutral
46.2 / 100
Mid-range Performer These stocks have average quality, financial and technical momentum, indicating a mid range performer View Similar Embed DVM
Analyst Price Target
353
1Yr Price target upside is 7%
30 analysts

4

S

5

W

2

O

2

T

SWOT Analysis

Amgen Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..